Literature DB >> 19453342

Evaluating the severity of dermatologic disorders.

Sarah J Grekin1, Charles N Ellis.   

Abstract

Assessment of a patient's disease severity is an essential component of formulating therapeutic strategies. However, disorders of the skin are often not amenable to strict classification criteria, and the dermatologist relies upon personal thresholds of severity when assessing the patient's overall condition. A number of grading systems have arisen, primarily from the need for standardized end points in clinical trials; in some circumstances, these severity assessments may assist the clinician in the evaluation and treatment of dermatologic disease. In this review, we will summarize the results of available severity scores of frequently encountered dermatologic disorders and discuss their utility in the management of disease in a clinician's office.

Entities:  

Mesh:

Year:  2009        PMID: 19453342     DOI: 10.1111/j.1529-8019.2009.01231.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

1.  The erythema Q-score, an imaging biomarker for redness in skin inflammation.

Authors:  John Frew; Lauren Penzi; Mayte Suarez-Farinas; Sandra Garcet; Patrick M Brunner; Tali Czarnowicki; Jaehwan Kim; Claire Bottomley; Robert Finney; Inna Cueto; Judilyn Fuentes-Duculan; Hanako Ohmatsu; Tim Lentini; Valerie Yanofsky; James G Krueger; Emma Guttman-Yassky; Daniel Gareau
Journal:  Exp Dermatol       Date:  2020-11-30       Impact factor: 3.960

2.  Evaluation of the effect of COVID-19 pandemic on dermatological diseases with dermatological quality life index.

Authors:  Munise Daye; Selami Aykut Temiz; Begüm Işık; Recep Dursun; Arzu Ataseven
Journal:  Dermatol Ther       Date:  2020-10-13       Impact factor: 3.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.